Actively Recruiting
Intravenous rhPro-UK Compared to Placebo Before Endovascular Thrombectomy for Large Vessel Occlusion Stroke in Extended Time Window
Led by First Affiliated Hospital Xi'an Jiaotong University · Updated on 2026-09-09
820
Participants Needed
10
Research Sites
13 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating intravenous recombinant human Prourokinase rhPro-UK in patients who have suffered an acute ischemic stroke caused by large vessel occlusion occurring 4.5 to 24 hours after the last known well time. This phase III, randomized, double-blind, placebo-controlled trial aims to determine if rhPro-UK improves blood flow before thrombectomy and enhances functional outcomes after 90 days, while also assessing potential risks like symptomatic brain bleeding and mortality. Participants will be randomly assigned to receive either an intravenous dose of rhPro-UK or a matching placebo. The rhPro-UK dose consists of 15 mg given as an intravenous push within 5 minutes, followed by a continuous infusion of 20 mg over 30 minutes. All participants will also undergo endovascular thrombectomy. The study includes a control group receiving placebo plus thrombectomy to compare outcomes. Throughout the study, participants will have neuroimaging scans such as CT, CTA, MRI, or MRA at 24 hours after treatment to evaluate reperfusion. Stroke severity will be assessed using the NIH Stroke Scale at 5 to 7 days or hospital discharge, and functional independence will be measured by the modified Rankin Scale at 90 days. Safety monitoring focuses on brain hemorrhage and mortality events. The trial is designed with blinded outcome assessment and independent safety oversight, lasting up to 90 days for primary outcomes.
CONDITIONS
Brief Title
Intravenous rhPro-UK Before Stroke Thrombectomy in the Extended Time Window (BRIDGE-PUK EXTEND)
Research Team
F
Fude Liu, MD
Y
Yawen Cheng, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here